4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-002825
SVP, Controller and PAO sold 4,000 shares at $140.65 ($562,600)
- SVP, Controller and PAO acquired 4,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Huizenga Theodore Alan · SVP, Controller and PAO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-07 | Exercise or conversion : show line 1 in the form | +4,000 | $21.00 | $84,000 | 20,436 | D |
| 2021-01-07 | Sale : show line 2 in the form | −4,000 | $140.65 | $562,600 | 15,716 | D |
| Open-market sales · 4,000 sh · avg $140.65 · $562,600 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-01-07 | Exercise or conversion : show line 3 in the form Stock Option | −4,000 | $21.00 | 2024-01-29 | 4,000 | 8,000 | D |
Loading xslF345X03/doc4.xml…